Last updated on January 2020

Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma


Brief description of study

This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.

Clinical Study Identifier: NCT03568461

Find a site near you

Start Over

UCSF Medical Center

San Francisco, CA United States
  Connect »

Novartis Investigative Site

Pierre Benite Cedex, France
  Connect »

Novartis Investigative Site

Birmingham, United Kingdom
  Connect »